Re: Rules on Disclosure
|
5
|
Resverlogix Corp.
|
Sep 26, 2019 10:29PM
|
Re: Diving into....
|
9
|
Resverlogix Corp.
|
Sep 28, 2019 10:13AM
|
Re: Diving into....
|
3
|
Resverlogix Corp.
|
Sep 28, 2019 10:21AM
|
Why Hepalink in the first place?
|
4
|
Resverlogix Corp.
|
Sep 28, 2019 07:38PM
|
Re: New Share Price Contest
|
1
|
Resverlogix Corp.
|
Oct 11, 2019 06:12PM
|
Re: Patent Application Publication 10/31/2019 CRYSTAL PHARMACEUTICAL (SUZHOU) CO., LTD. (Suzhou, Jiangsu, CN)
|
4
|
Resverlogix Corp.
|
Nov 04, 2019 10:01AM
|
Re: Buyers need sellers....why I think delivery failures are important
|
3
|
Resverlogix Corp.
|
Nov 09, 2019 01:36PM
|
Re: RESVERLOGIX ANNOUNCES WARRANT EXERCISE INCENTIVE PROGRAM
|
3
|
Resverlogix Corp.
|
Nov 25, 2019 06:26PM
|
Re: Resverlogix Announces Change to its Board of Directors
|
8
|
Resverlogix Corp.
|
Dec 11, 2019 09:56AM
|
Re: Hepalink up 8.65%
|
4
|
Resverlogix Corp.
|
Feb 05, 2020 09:00AM
|
DM Interview w Jane King (Innovators) Apr 7 - COVID 19
|
14
|
Resverlogix Corp.
|
Apr 08, 2020 08:38PM
|
Re: Rules of thumb and broken thumbs...
|
3
|
Resverlogix Corp.
|
Sep 29, 2020 04:05PM
|
Apabetalone and Potential COVID-19 Effectiveness
|
12
|
Resverlogix Corp.
|
Oct 26, 2020 09:01AM
|
Re: By Christmas time.....
|
10
|
Resverlogix Corp.
|
Dec 09, 2020 04:15PM
|
Some additional COVID 19 gene targets
|
3
|
Resverlogix Corp.
|
Dec 11, 2020 06:15PM
|
Institutional Investors
|
1
|
Resverlogix Corp.
|
Dec 11, 2020 07:02PM
|
Inventory and Revenue calcs
|
9
|
Resverlogix Corp.
|
May 13, 2021 11:01AM
|
COVID trial now in CTD
|
10
|
Resverlogix Corp.
|
May 15, 2021 11:51AM
|
Re: COVID trial now in CTD
|
3
|
Resverlogix Corp.
|
May 15, 2021 01:00PM
|
Anne McCaffrey passing
|
17
|
Resverlogix Corp.
|
Jun 04, 2021 11:51AM
|